CITELINE
LIVE

Serial Number

79103969

Owner

Informa UK Limited

Attorney

Jessica S. Sachs

Filing Date

Mar 31, 2011

Add to watchlist:

No watchlists yet
View on USPTO

CITELINE Trademark

Serial Number: 79103969 • Registration: 4762279

CITELINE is a trademark filed by Informa UK Limited on March 31, 2011. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

Informa UK Limited (69 trademarks)

5 Howick Place
London SW1P1WG , GB

Entity Type: 11

Citeline, Inc. (6 trademarks)

605 3rd Avenue
New York, NY 10158

Entity Type: 03

PHARMA INTELLIGENCE U.K. LIMITED (22 trademarks)

3 More London Riverside
LONDON SE1 2AQ , GB

Entity Type: 24

Caerus US 1 Inc.

Corporation Trust Center
Wilmington, New Castle County, DE 19801

Entity Type: 03

Informa Business Intelligence, Inc.

52 Vanderbilt
New York, NY 10017

Entity Type: 03

Trademark Details

Filing Date

March 31, 2011

Registration Date

June 30, 2015

Published for Opposition

April 14, 2015

Goods & Services

[ Medical services; ] advisory medical services and the provision of medical information; [dentistry services; advisory medical services and the provision of information relating to dentistry; ] advisory services and the provision of information relating to health; [ consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following the administration of chemical, biological radiological or nuclear materials; providing medical information, consultancy and advisory services in the field of pharmaceuticals; medical information in the field of pharmaceuticals; dispensing of pharmaceuticals; veterinary services; medical testing services for diagnostic and treatment purposes; surgical treatment services; advisory services and the provision of medical information relating to surgery; advisory services and the provision of medical information relating to cosmetic surgery; advisory services and the provision of medical information relating to cosmetic treatment; hygienic and beauty care for human beings; hygienic and beauty care for animals; beauty therapy services, namely, medical, hygienic and beauty care services; information, consultancy and advisory services relating to all the aforesaid services; ] information, consultancy and advisory services in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare relating to all the aforesaid services provided on-line

Education services, namely, providing educational seminars, [ conferences, classes and workshops ] in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; [ Training services in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; entertainment and recreational services, namely, sporting and cultural events, training and educational conferences, courses, seminars and exhibitions in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Publishing and issuing of scientific papers in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] Electronic publishing services, namely, publication of text and graphic works of others online featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare [ ; the provision of news online in the nature of news agencies, namely, gathering and dissemination of news; Nondownloadable electronic publications in the nature of journals, newsletters, reports, and directories in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare via the Internet ]

[ Apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers, prerecorded magnetic data carriers featuring information and data in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; blank recording optical discs; pre-recorded CDs, video tapes, laser disks and DVDs featuring information in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; downloadable computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare and manuals in electronic format sold as a unit; computer software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] downloadable electronic publications in the nature of [ newsletters, ] reports, [ directories and bulletins ] in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare from databases or the internet; downloadable electronic publications and information, namely, [ newsletters, ] reports, [ directories and bulletins ] in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare provided on-line from databases or the internet; [ computer programs featuring programming languages in electronic form for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; prerecorded magnetic, electronic or optical data carriers featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] electronic publications, namely, instruction manuals recorded on computer media relating to use of computers and to data, all recorded magnetically, optically or electronically [ ; magnetic, optical and electronic data recording apparatus for recording of sound, images or data ]

[ Medical services; advisory medical services and the provision of medical information; dentistry services; advisory medical services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following the administration of chemical, biological radiological or nuclear materials; providing medical information, consultancy and advisory services in the field of pharmaceuticals; medical information in the field of pharmaceuticals; dispensing of pharmaceuticals; veterinary services; medical testing services for diagnostic and treatment purposes; surgical treatment services; advisory services and the provision of medical information relating to surgery; advisory services and the provision of medical information relating to cosmetic surgery; advisory services and the provision of medical information relating to cosmetic treatment; hygienic and beauty care for human beings; hygienic and beauty care for animals; beauty therapy services, namely, medical, hygienic and beauty care services; information, consultancy and advisory services relating to all the aforesaid services; information, consultancy and advisory services ] [ in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare ] [ relating to all the aforesaid services provided on-line]

[ Paper and cardboard; goods made from paper or cardboard not included in other classes, namely, boxes, cartons, storage containers, and packaging containers; printed materials, namely, journals, newsletters, reports, and directories featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; printed instructional materials in the field of computer software and programmes; book-binding material; photographs; stationery; printed instructional, educational, and teaching materials in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare ]

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 8, 2026 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 8, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Sep 8, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 8, 2025 APRE
TEAS SECTION 71 RECEIVED
Jun 2, 2025 ES71
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 30, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 30, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 30, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 30, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 30, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 30, 2025 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 4, 2025 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
Nov 29, 2024 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 19, 2024 INPS
INVALIDATION PROCESSED
Sep 19, 2024 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 13, 2024 INPR
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jun 30, 2024 REM4
CHANGE OF OWNER RECEIVED FROM IB
Mar 7, 2024 DCPN
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jan 12, 2024 NA75
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 12, 2024 APRE
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
Jan 12, 2024 PRAN
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Jan 12, 2024 C75P
REGISTERED - SEC. 7 REQUEST ABANDONED
Jan 12, 2024 PRA7
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 10, 2024 APRE
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Mar 24, 2023 INNA
CHANGE OF OWNER RECEIVED FROM IB
Feb 25, 2023 CHLD
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 7, 2023 INPR
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Dec 6, 2022 EROP
TEAS SECTION 7 REQUEST RECEIVED
Nov 30, 2022 ES7R
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Jun 7, 2022 PR75
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 6, 2022 APRE
TEAS SECTION 71 & 15 RECEIVED
Dec 29, 2021 ES75
INTERNATIONAL REGISTRATION RENEWED
May 20, 2021 RNWL
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 30, 2020 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 26, 2017 ADCH
CHANGE OF OWNER RECEIVED FROM IB
Jan 5, 2017 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Aug 4, 2016 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 17, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 26, 2015 FICS
FINAL DISPOSITION PROCESSED
Oct 26, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 30, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 30, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2015 NPUB
PUBLISHED FOR OPPOSITION
Apr 14, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Apr 10, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 25, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 25, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 25, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 6, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2015 CNSA
ASSIGNED TO LIE
Jan 20, 2015 ALIE
CHANGE OF OWNER RECEIVED FROM IB
Oct 16, 2014 CHLD
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 16, 2014 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 16, 2014 GNSL
SUSPENSION LETTER WRITTEN
Jul 16, 2014 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2014 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 8, 2014 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 9, 2014 GNFN
FINAL REFUSAL E-MAILED
Jan 9, 2014 GNFR
FINAL REFUSAL WRITTEN
Jan 9, 2014 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 23, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 23, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 23, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 28, 2013 GNRN
NON-FINAL ACTION E-MAILED
Jun 28, 2013 GNRT
NON-FINAL ACTION WRITTEN
Jun 28, 2013 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 28, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 28, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 28, 2013 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 20, 2013 OPNX
NEW REPRESENTATIVE AT IB RECEIVED
Apr 5, 2013 NREP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 3, 2013 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 3, 2013 OPNR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 27, 2012 GNRN
NON-FINAL ACTION E-MAILED
Nov 27, 2012 GNRT
NON-FINAL ACTION WRITTEN
Nov 27, 2012 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2012 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 31, 2012 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 8, 2012 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 8, 2012 GNSL
SUSPENSION LETTER WRITTEN
Jun 8, 2012 CNSL
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jun 6, 2012 LIMN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 25, 2012 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 25, 2012 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
May 9, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 9, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 9, 2012 TROA
LIMITATION OF GOODS RECEIVED FROM IB
May 4, 2012 LIMG
REFUSAL PROCESSED BY IB
Dec 19, 2011 RFNT
REFUSAL PROCESSED BY IB
Nov 27, 2011 RFNT
APPLICATION FILING RECEIPT MAILED
Nov 11, 2011 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 10, 2011 RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 10, 2011 RFCS
REFUSAL PROCESSED BY MPU
Nov 10, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 10, 2011 RFCR
NON-FINAL ACTION WRITTEN
Nov 9, 2011 CNRT
REFUSAL PROCESSED BY MPU
Nov 8, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 8, 2011 RFCR
NON-FINAL ACTION WRITTEN
Nov 7, 2011 CNRT
ASSIGNED TO EXAMINER
Nov 7, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 3, 2011 REPR